IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMAIONI, Emidio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.029
EU - Europa 3.706
AS - Asia 3.535
SA - Sud America 595
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 12.963
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.917
SG - Singapore 1.674
UA - Ucraina 673
IE - Irlanda 614
IT - Italia 592
RU - Federazione Russa 500
CN - Cina 483
BR - Brasile 459
HK - Hong Kong 453
VN - Vietnam 297
DE - Germania 280
SE - Svezia 264
FI - Finlandia 201
FR - Francia 200
GB - Regno Unito 131
TR - Turchia 106
KR - Corea 97
BD - Bangladesh 89
IN - India 86
PL - Polonia 58
CA - Canada 46
AR - Argentina 45
MX - Messico 38
IQ - Iraq 33
NL - Olanda 33
JP - Giappone 30
CO - Colombia 28
CH - Svizzera 27
UZ - Uzbekistan 26
BE - Belgio 23
ID - Indonesia 22
PK - Pakistan 22
AT - Austria 21
CZ - Repubblica Ceca 20
ES - Italia 17
ZA - Sudafrica 17
VE - Venezuela 15
EC - Ecuador 14
PH - Filippine 14
EG - Egitto 13
CL - Cile 12
GR - Grecia 12
MA - Marocco 12
RO - Romania 12
TN - Tunisia 12
AZ - Azerbaigian 11
JO - Giordania 11
LB - Libano 10
PY - Paraguay 10
LT - Lituania 9
SA - Arabia Saudita 9
IL - Israele 8
JM - Giamaica 8
MY - Malesia 7
NP - Nepal 7
EU - Europa 6
OM - Oman 6
DZ - Algeria 5
KZ - Kazakistan 5
LY - Libia 5
PE - Perù 5
SV - El Salvador 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
ET - Etiopia 4
KE - Kenya 4
PA - Panama 4
AM - Armenia 3
HN - Honduras 3
SN - Senegal 3
TH - Thailandia 3
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
NE - Niger 2
NG - Nigeria 2
PS - Palestinian Territory 2
PT - Portogallo 2
TM - Turkmenistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
Totale 12.943
Salva come PNG Salva come JPEG
Città #
Singapore 1.124
Dublin 609
Chandler 556
San Jose 523
Hong Kong 448
Jacksonville 409
San Mateo 336
Ashburn 286
Boardman 214
Santa Clara 209
Perugia 193
Moscow 173
Altamura 165
Medford 156
Princeton 154
Lauterbourg 140
Dong Ket 119
Beijing 114
Lawrence 105
Wilmington 104
Ann Arbor 97
Seoul 97
Munich 87
Andover 86
Los Angeles 82
Izmir 77
New York 70
The Dalles 61
Redmond 58
Des Moines 56
Ho Chi Minh City 51
Saint Petersburg 49
São Paulo 43
Hanoi 41
Helsinki 35
Piscataway 33
Orem 27
Turku 27
Dallas 25
Tokyo 25
Chicago 24
London 23
Norwalk 23
Rome 22
Brussels 21
San Paolo di Civitate 21
Brooklyn 20
Chennai 18
Denver 18
Nuremberg 18
Woodbridge 18
Mexico City 17
Montreal 17
Phoenix 17
Tashkent 17
San Francisco 16
Warsaw 16
Baghdad 15
Boston 15
Shanghai 15
Houston 14
Poplar 14
Rio de Janeiro 14
Johannesburg 13
Milan 13
Atlanta 12
Charlotte 12
Stockholm 12
Belo Horizonte 11
Bucharest 11
Den Haag 11
Haiphong 11
Manchester 11
Redwood City 11
Ankara 10
Auburn Hills 10
Amsterdam 9
Baku 9
Medellín 9
Toronto 9
Zhengzhou 9
Amman 8
Bogotá 8
Council Bluffs 8
Falls Church 8
New Delhi 8
Olomouc 8
Tianjin 8
Brno 7
Cairo 7
Hefei 7
Krakow 7
San Diego 7
Seattle 7
Annapolis 6
Bologna 6
Brasília 6
Buffalo 6
Casablanca 6
Florence 6
Totale 8.004
Salva come PNG Salva come JPEG
Nome #
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 179
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 161
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 135
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 134
Biochemical Studies on Human Ornithine Aminotransferase Support a Cell-Based Enzyme Replacement Therapy in the Gyrate Atrophy of the Choroid and Retina 132
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 128
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 128
Structure-activity relationships of bisphophonate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists 125
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 125
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 125
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 123
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 122
Binding Mode of 6ECDCA, a Potent Bile Acid Agonist of the Farnesoid X Receptor (FXR) 121
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors 119
Spiro[2.2]pentane as a Dissymmetric Scaffold for Conformationally Constrained Analogues of Glutamic Acid: Focus on Racemic 1-Aminospiro[2.2]pentyl-1,4-dicarboxylic Acids 118
Towards New Neuroprotective Agents: Design and Synthesis of Thieno[2,3-c]-isoquinolinon-5-one as a Potent PARP-1 Inhibitor. 117
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 115
Spiro[2.2]pentane as a dyssymetric scaffold for conformationally constrained analogues of glutamic acid: diastereodivergent synthesis of 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 114
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 111
Chiral separation of helical chromenes with chloromethyl phenylcarbamate polysaccharide-based stationary phases 110
Metabotropic glutamate receptors: structure and new subtype-selective ligands 109
Targeting the FXR nuclear receptor through a virtual screening approach 109
Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA 108
Preparation and use of nucleotide bisphosphate as P2Y antagonists 107
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. 107
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. 106
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases 106
Design and synthesis of 4H-thieno[2,3-c]isoquinolin-5-one derivatives as potent PARP-1 inhibitors, on route of new antiischemic agents 105
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 105
Design, Molecular Modeling Studies, Synthesis and Preliminary Evaluation of Novel PARP-1 Inhibitors on the Road of Antiischemic Agents 104
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. 104
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 104
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 104
The relationship between s. Aureus and branched-chain amino acids content in composite cow milk 104
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 103
PARP inhibitors: polypharmacology versus selective inhibition 103
Circular Hazelnut Protection by Lignocellulosic Waste Valorization for Nanopesticides Development 103
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage 102
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 100
Novel PARP Inhibitors: Synthesis and Molecular Modeling Studies 99
Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors 98
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. 98
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 98
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. 98
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids. 97
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 97
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 96
Dexpramipexole improves bioenergetics and outcome in experimental stroke 96
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and QSAR 95
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis 95
Rat Brain Guanosine Binding Site:Biological Studies and Pseudo Receptor Construction 94
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 93
Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogues: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 93
Rat brain guanosine binding site. Biological studies and pseudo-Receptor construction 92
Pharmacology of the highly selective A1 adenosine receptor agonist2-chloro-N6-cyclopentyladenosine. 92
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 92
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 92
Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues 92
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 91
Branched-chain amino acids as potential diagnostic and prognostic disease biomarkers 91
A Green Nanostructured Pesticide to Control Tomato Bacterial Speck Disease 91
Bile acids: property-activity relationship and molecular modelling studies 90
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide. 89
8-Bromo-9-etiladenine come tools per l’ottenimento di antagonisti selettivi per il recettore adenosinico A2B 89
Effects of Molecular Dynamics and Replica Exchange Molecular Dynamics in Sampling the Conformational Space of PARP-1 89
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 88
Boosting Immunity and Management against Wheat Fusarium Diseases by a Sustainable, Circular Nanostructured Delivery Platform 87
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 87
Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids 87
Molecular determinats for metabotropic glutamate receptor activation and blockade. Molecular dynamics and electrostatic potential analysis studies 87
Hydrophobic Amino Acid Content in Onions as Potential Fingerprints of Geographical Origin: The Case of Rossa da Inverno sel. Rojo Duro 87
Effects of new arylazido compounds of pyridoxal phosphate on ecto-ATPase activity of guinea pig tissues 85
Insights in the PARP1 poisoning effect 85
Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin 84
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure Activity Relationship of a Series of Body and Side Chain Modified Analogs of Chenodeoxycholic Acid 83
Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 82
The relationships between somatic cells and isoleucine, leucine and tyrosine content in cow milk 82
Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C 82
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent 81
Quantitative analysis of cucurbitane-type triterpenes in Ibervillea sonorae extracts: Relationship study with their antiproliferative activity 81
Synthesis, molecular modelling and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO) 79
Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) 77
Fast chromatographic determination of the bile salt critical micellar concentration 76
Synthesis and Receptor Affinity of Polysubstituted Adenosines 76
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 75
Synthesis and Biological Evaluation of 2-(3’-(1H-tetrazol-5-yl)bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 Receptor 74
Dominant Factors Affecting the Chromatographic Behaviour of Bile Acids 74
HYDAMTIQ: A New, Potent PARP-1 Inhibitor with Neuroprotective Properties 74
Combined strategies toward the design and synthesis, of novel inhibitors of indoleamine-2,3-dioxygenase (IDO) 74
Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase 74
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 74
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 73
Studies on the interaction between PARP’s catalytic site and inhibitors. Design and synthesis of new class of inhibitor derivatives 72
On the Way to Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 72
Characterization of the novel poly(ADP-ribose) polymerase (PARP) inhibitor thieno[2,3-c]isoquinolin-5-one (TIQ): neuroprotective effects models of cerebral ischemia 72
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 72
Towards Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 71
Novel Isoquinoline-Derived Inhibitors of Poly(ADP-Ribose) Polymerase-1: Pharmacological Characterization and Neuroprotective Effects in an in Vitro Model of Cerebral Ischemia 71
Xaa-prolyl dipeptidyl aminopeptidase may play an important role in biofilm formation by Streptococcus mutans 70
Human P2Y(1) receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites 69
Totale 9.709
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.717
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 0 0 0 0 0 0 0 145
2021/20221.214 33 212 11 54 37 11 13 405 43 51 138 206
2022/20232.058 165 391 30 121 178 215 3 83 760 7 76 29
2023/2024851 47 104 44 12 7 15 182 29 88 28 132 163
2024/20252.064 22 202 73 62 252 105 122 93 442 154 319 218
2025/20264.545 339 357 251 529 591 360 829 175 527 389 133 65
Totale 13.375